Fisher & Paykel Healthcare Corporation Limited
FSPKFOTCHealthcare● Active
$22.52
+$0.00(+0.00%)
Market Cap$13.2B
P/E Ratio—
52W High$25.69
52W Low$16.35
Fisher & Paykel Healthcare Corporation Limited (FSPKF) · Cash Flow
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · FSPKF · as of 2026-06-13
Financial statements
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.47B | $0.21B | $0.13B | $0.25B | $0.38B |
| Depreciation & Amort. | $0.16B | $0.08B | $0.11B | $0.10B | $0.10B |
| Stock-Based Comp. | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| Change in Working Capital | $0.02B | ($0.07B) | $0.01B | ($0.07B) | ($0.04B) |
| Net Cash from Operations | $0.67B | $0.55B | $0.43B | $0.24B | $0.32B |
| Investing Activities | |||||
| Capital Expenditure | ($0.17B) | ($0.10B) | ($0.34B) | ($0.21B) | ($0.17B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Sales of Investments | $0.00B | $0.00B | $0.00B | $0.20B | $0.08B |
| Net Cash from Investing | ($0.20B) | ($0.10B) | ($0.34B) | ($0.01B) | ($0.09B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Dividends Paid | ($0.25B) | ($0.20B) | ($0.15B) | ($0.20B) | ($0.22B) |
| Debt Issued / Repaid | ($0.01B) | ($0.06B) | $0.03B | $0.01B | ($0.00B) |
| Net Cash from Financing | ($0.28B) | ($0.27B) | ($0.13B) | ($0.20B) | ($0.24B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.50B | $0.45B | $0.09B | $0.03B | $0.15B |
| FCF Margin %(computed) | 20.97% | 34.80% | 5.15% | 1.69% | 9.41% |
Data source: Financial Modeling Prep · Last updated: 2026-06-13 · NZD · B
Explore more Fisher & Paykel Healthcare Corporation Limited data
About Fisher & Paykel Healthcare Corporation Limited (FSPKF) Cash Flow Statement
Fisher & Paykel Healthcare Corporation Limited generated operating cash flow of $0.67B and free cash flow of $0.50B for 2026 — a FCF margin of 20.97%. Capital expenditure was ($0.17B).
Frequently asked questions
FSPKF · 4 questionsFisher & Paykel Healthcare Corporation Limited generated free cash flow of $0.50B for 2026, up 11.2% year-over-year.
FSPKF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-13